NASP Comments to CMS on Part B Drug Proposal NASP comments on the organization’s concerns over the CMS proposed plan. Download PDF for details.
About NASP | Contact Us | Privacy Policy ©2016-2019 National Association of Specialty Pharmacy 300 New Jersey Avenue NW, Suite 900 Washington, D.C. 20001 703.842.0122